Table 2.
Minimum Inhibitory Concentrations of the Methicillin-Resistant Staphylococcus aureus Isolates Associated with Clinical Disease in Dwarf (Helogale parvula) and Yellow Mongooses (Cynictis penicillata)
| MIC (μg/ml) | Mo1 | Mo2 | Mo3 | Mo4 (37°C) | Mo4 (25°C) |
|---|---|---|---|---|---|
| Penicillin | 4 | 4 | 4 | 0.5 | >8 |
| Ampicillin | 4 | 4 | 4 | 0.5 | 8 |
| Amoxicillin/clavulanic acid | ≤4 | ≤4 | ≤4 | ≤4 | 8 |
| Cefazolin | ≤4 | ≤4 | ≤4 | ≤4 | >16 |
| Cefovecin | 4 | 4 | 4 | 1 | >8 |
| Cefoxitin | 4 | 4 | 4 | ≤2 | >16 |
| Oxacillin | 1 | 1 | 1 | 0.5 | >4 |
| Cefpodoxime | 4 | 4 | 4 | ≤2 | >16 |
| Ceftiofur | 4 | 4 | 4 | 1 | >4 |
| Ticarcillina | 16 | 16 | 16 | ≤8 | 64 |
| Ticarcillin/clavulanic acida | ≤8 | ≤8 | ≤8 | ≤8 | 32 |
| Amikacin | ≤4 | ≤4 | ≤4 | ≤4 | ≤4 |
| Chloramphenicola | >16 | >16 | >16 | 8 | ≤4 |
| Clindamycin | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 |
| Doxycycline | >8 | >8 | >8 | ≤2 | ≤2 |
| Enrofloxacin | >2 | >2 | >2 | ≤0.25 | ≤0.25 |
| Erythromycin | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 |
| Gentamicin | ≤1 | ≤1 | ≤1 | ≤1 | ≤1 |
| Marbofloxacin | >2 | >2 | >2 | 0.5 | ≤0.25 |
| Rifampin | ≤1 | ≤1 | ≤1 | ≤1 | ≤1 |
| Trimethoprim/sulfamethoxazole | >2 | >2 | >2 | ≤0.5 | ≤0.5 |
a
For interpretation of test results EUCAST breakpoints (v. 6.0) were used. Values shown in bold = resistant.
MIC, minimum inhibitory concentration.